Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
186
-
Total 13F shares, excl. options
-
108,273,662
-
Shares change
-
+15,263,951
-
Total reported value, excl. options
-
$1,614,512,313
-
Value change
-
+$248,853,575
-
Put/Call ratio
-
107%
-
Number of buys
-
114
-
Number of sells
-
76
-
Price
-
$14.91
Institutional Holders of CYMABAY THERAPEUTICS INC - COM (CBAY) as of Q3 2023
As of 30 Sep 2023 CYMABAY THERAPEUTICS INC - COM (CBAY) had 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 108,273,662 shares of stock of the company.
Largest 10 holders included Avoro Capital Advisors LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LP, JENNISON ASSOCIATES LLC, and FRANKLIN RESOURCES INC.
This table shows 236 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.